CABOZANTINIB

CABOZANTINIB was reported 48250 times

CABOZANTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SCROTAL DERMATITIS 13 0.2063
1 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3165 0.1357
2 RENAL CELL CARCINOMA RECURRENT 15 0.1181
3 RENAL CELL CARCINOMA 504 0.1029
4 THYROID HORMONES INCREASED 107 0.1018
5 TASTE DISORDER 2010 0.0990
6 THYROID HORMONES DECREASED 76 0.0950
7 RENAL CANCER RECURRENT 13 0.0884
8 HYPERKERATOSIS 467 0.0846
9 RENAL CANCER METASTATIC 57 0.0740
10 SCROTAL ERYTHEMA 12 0.0723
11 GENITAL BLISTER 20 0.0722
12 METASTASES TO PANCREAS 30 0.0677
13 NASAL ULCER 101 0.0633
14 ALPHA 1 FOETOPROTEIN INCREASED 40 0.0562
15 TONGUE DISCOMFORT 229 0.0539
16 HAIR COLOUR CHANGES 671 0.0539
17 ORAL PAIN 1195 0.0533
18 GLOSSITIS 188 0.0529
19 GENITAL RASH 75 0.0525
20 METASTATIC RENAL CELL CARCINOMA 96 0.0524
21 TUMOUR PAIN 68 0.0516
22 CANCER PAIN 131 0.0512
23 STOMATITIS 2934 0.0483
24 SCROTAL ULCER 12 0.0460
25 SKIN ULCER 1147 0.0443
26 HAND-FOOT-AND-MOUTH DISEASE 36 0.0435
27 PRODUCT SELECTION ERROR 47 0.0428
28 TONGUE ERYTHEMA 35 0.0425
29 TONGUE ULCERATION 131 0.0387
30 METASTASES TO ABDOMINAL CAVITY 19 0.0386
31 PLICATED TONGUE 18 0.0377
32 BLISTER 2106 0.0375
33 GENITAL ERYTHEMA 18 0.0363
34 HEPATOCELLULAR CARCINOMA 264 0.0347
35 CLEAR CELL RENAL CELL CARCINOMA 24 0.0345
36 MALIGNANT NEOPLASM PROGRESSION 3476 0.0339
37 DIVERTICULITIS INTESTINAL PERFORATED 12 0.0336
38 PHARYNGEAL ULCERATION 44 0.0332
39 IMMUNE-MEDIATED HEPATIC DISORDER 63 0.0323
40 TUMOUR ASSOCIATED FEVER 13 0.0318
41 SENSITIVE SKIN 229 0.0310
42 METASTASES TO STOMACH 12 0.0306
43 ASYMPTOMATIC COVID-19 12 0.0305
44 BONE NEOPLASM 32 0.0297
45 HYPOTHYROIDISM 946 0.0296
46 RADIOTHERAPY 55 0.0287
47 PROTEIN URINE 26 0.0287
48 PROTEINURIA 541 0.0284
49 METASTASES TO ADRENALS 26 0.0282
50 HEPATIC FUNCTION ABNORMAL 1050 0.0281
51 IMMUNE-MEDIATED NEPHRITIS 13 0.0277
52 GLOSSODYNIA 616 0.0275
53 IMMUNE-MEDIATED HEPATITIS 56 0.0274
54 TONGUE BLISTERING 61 0.0273
55 AGEUSIA 668 0.0268
56 IMMUNE-MEDIATED ENCEPHALITIS 14 0.0265
57 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 21 0.0263
58 BLOOD CHROMOGRANIN A INCREASED 12 0.0261
59 GENITAL ULCERATION 20 0.0260
60 METASTASES TO LUNG 296 0.0256
61 GINGIVAL PAIN 202 0.0254
62 IMMUNE-MEDIATED HYPOTHYROIDISM 28 0.0248
63 DYSPHONIA 1424 0.0243
64 MALIGNANT PLEURAL EFFUSION 41 0.0243
65 GINGIVAL DISCOMFORT 16 0.0242
66 VERTEBRAL LESION 12 0.0234
67 METASTASES TO SPINE 78 0.0232
68 BLOOD THYROID STIMULATING HORMONE INCREASED 213 0.0231
69 ANGULAR CHEILITIS 16 0.0231
70 ORAL DISCOMFORT 321 0.0231
71 SCROTAL PAIN 12 0.0222
72 HYPERAESTHESIA TEETH 28 0.0222
73 IMMUNE-MEDIATED LUNG DISEASE 40 0.0219
74 INTRA-ABDOMINAL FLUID COLLECTION 39 0.0218
75 SKIN TOXICITY 123 0.0217
76 THYROID FUNCTION TEST ABNORMAL 89 0.0214
77 BLOOD PRESSURE INCREASED 3218 0.0210
78 TUMOUR NECROSIS 22 0.0208
79 ANAL ULCER 17 0.0208
80 GASTROINTESTINAL MOTILITY DISORDER 110 0.0205
81 IMMUNE-MEDIATED ENTEROCOLITIS 75 0.0204
82 BLOOD MAGNESIUM DECREASED 176 0.0204
83 NASAL SEPTUM PERFORATION 13 0.0201
84 DECREASED APPETITE 4671 0.0201
85 NONINFECTIVE GINGIVITIS 29 0.0200
86 ENZYME LEVEL INCREASED 17 0.0200
87 THYROIDITIS 60 0.0200
88 SKIN EROSION 64 0.0198
89 PROTEIN URINE PRESENT 99 0.0198
90 ADRENAL DISORDER 38 0.0198
91 ONYCHALGIA 19 0.0189
92 IMMUNE-MEDIATED DERMATITIS 19 0.0188
93 PRODUCT PRESCRIBING ISSUE 401 0.0184
94 RENAL SURGERY 12 0.0184
95 ADRENAL INSUFFICIENCY 223 0.0184
96 THYROID DISORDER 281 0.0182
97 TUMOUR HAEMORRHAGE 51 0.0179
98 PRODUCT INEFFECTIVE 14 0.0178
99 LIP PAIN 51 0.0178
100 HYPOGEUSIA 34 0.0173
101 APPETITE DISORDER 109 0.0164
102 TOOTH DISORDER 363 0.0163
103 CELL DEATH 32 0.0161
104 HYPOPITUITARISM 27 0.0155
105 MUCOSAL INFLAMMATION 404 0.0154
106 METASTASES TO BONE 253 0.0154
107 FEEDING DISORDER 312 0.0154
108 ADVERSE DRUG REACTION 1369 0.0152
109 ORAL MUCOSAL ERUPTION 23 0.0150
110 LIVER FUNCTION TEST INCREASED 318 0.0148
111 DIARRHOEA 9557 0.0148
112 PALMAR ERYTHEMA 17 0.0147
113 DRUG TOLERANCE DECREASED 41 0.0146
114 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 18 0.0144
115 LYMPHANGIOSIS CARCINOMATOSA 15 0.0144
116 METASTASES TO PLEURA 15 0.0143
117 NASAL DRYNESS 88 0.0140
118 TONGUE DRY 19 0.0140
119 PULMONARY CAVITATION 12 0.0138
120 ORAL DISORDER 101 0.0138
121 PANCREATIC ENZYMES INCREASED 20 0.0137
122 BLOOD THYROID STIMULATING HORMONE ABNORMAL 25 0.0136
123 ORAL MUCOSAL ERYTHEMA 21 0.0136
124 AMYLASE INCREASED 50 0.0135
125 GASTROINTESTINAL TOXICITY 65 0.0135
126 SKIN DEPIGMENTATION 18 0.0132
127 BLOOD SODIUM ABNORMAL 14 0.0132
128 ASPARTATE AMINOTRANSFERASE ABNORMAL 20 0.0131
129 BILIARY OBSTRUCTION 17 0.0131
130 RHINALGIA 36 0.0131
131 BONE LESION 47 0.0130
132 IMMUNE-MEDIATED MYOCARDITIS 21 0.0130
133 METASTASES TO CENTRAL NERVOUS SYSTEM 166 0.0129
134 IMPAIRED HEALING 415 0.0126
135 BLOOD BILIRUBIN ABNORMAL 16 0.0125
136 NAIL DISCOLOURATION 49 0.0125
137 DRY MOUTH 1009 0.0124
138 NEPHROTIC SYNDROME 85 0.0124
139 BLOOD CALCIUM DECREASED 139 0.0123
140 DYSGEUSIA 917 0.0123
141 MUCOSAL DISORDER 12 0.0121
142 VENA CAVA THROMBOSIS 20 0.0120
143 HEPATIC ENZYME ABNORMAL 60 0.0120
144 ALANINE AMINOTRANSFERASE ABNORMAL 25 0.0118
145 DERMATITIS ACNEIFORM 72 0.0118
146 HYPERTHYROIDISM 167 0.0115
147 HYPERTRANSAMINASAEMIA 80 0.0115
148 ACQUIRED GENE MUTATION 15 0.0114
149 LUNG ABSCESS 24 0.0114
150 BLOOD ELECTROLYTES ABNORMAL 14 0.0113
151 SKIN FISSURES 221 0.0113
152 PANCREATIC MASS 12 0.0112
153 SMALL INTESTINAL PERFORATION 21 0.0112
154 GINGIVAL SWELLING 49 0.0111
155 WEIGHT DECREASED 3087 0.0110
156 CONSTIPATION 2405 0.0110
157 HYPOALBUMINAEMIA 85 0.0109
158 SKIN HYPERTROPHY 30 0.0107
159 LIVER DISORDER 471 0.0106
160 SKIN ATROPHY 61 0.0106
161 RENAL FUNCTION TEST ABNORMAL 49 0.0105
162 HYPOPROTEINAEMIA 20 0.0105
163 CORTISOL DECREASED 12 0.0105
164 FAECES SOFT 76 0.0104
165 IMMUNE-MEDIATED ADVERSE REACTION 16 0.0104
166 WOUND DEHISCENCE 35 0.0103
167 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1864 0.0103
168 DECUBITUS ULCER 84 0.0103
169 PERFORMANCE STATUS DECREASED 48 0.0103
170 LIP BLISTER 28 0.0103
171 RECTAL ULCER 12 0.0102
172 CHEILITIS 55 0.0102
173 FATIGUE 7795 0.0100
174 HYPOPHYSITIS 20 0.0099
175 DRY SKIN 1320 0.0099
176 GINGIVAL BLEEDING 135 0.0099
177 BLOOD PRESSURE FLUCTUATION 237 0.0099
178 GASTROINTESTINAL PERFORATION 41 0.0099
179 BLOOD ELECTROLYTES DECREASED 14 0.0098
180 OROPHARYNGEAL BLISTERING 16 0.0098
181 PNEUMATOSIS INTESTINALIS 28 0.0098
182 DRY THROAT 99 0.0097
183 PHYSICAL DECONDITIONING 25 0.0097
184 METASTASES TO LIVER 169 0.0096
185 BLOOD SODIUM DECREASED 181 0.0096
186 SKIN EXFOLIATION 806 0.0095
187 FAECES PALE 21 0.0094
188 SKIN WOUND 16 0.0094
189 METASTASES TO LYMPH NODES 63 0.0093
190 NEOPLASM 107 0.0093
191 TENDERNESS 97 0.0093
192 PROTEIN TOTAL ABNORMAL 12 0.0092
193 LIPASE INCREASED 70 0.0091
194 HYPERTENSION 1928 0.0091
195 BLOOD PRESSURE DIASTOLIC INCREASED 42 0.0091
196 HEPATIC ENZYME INCREASED 616 0.0090
197 BLOOD CALCIUM ABNORMAL 15 0.0090
198 BONE CANCER 39 0.0090
199 PULMONARY PAIN 26 0.0089
200 RED BLOOD CELL COUNT ABNORMAL 13 0.0088
201 PNEUMOTHORAX 140 0.0088
202 TINEA PEDIS 14 0.0088
203 PROTEIN TOTAL DECREASED 33 0.0088
204 LARGE INTESTINE PERFORATION 60 0.0086
205 APHTHOUS ULCER 67 0.0086
206 AMMONIA INCREASED 44 0.0086
207 ORAL MUCOSAL EXFOLIATION 13 0.0086
208 APHONIA 119 0.0085
209 SKIN HYPOPIGMENTATION 15 0.0085
210 APPENDIX DISORDER 12 0.0085
211 PATHOLOGICAL FRACTURE 43 0.0085
212 INGROWING NAIL 20 0.0085
213 BLOOD ALBUMIN DECREASED 67 0.0084
214 SKIN DISORDER 280 0.0084
215 FLATULENCE 476 0.0084
216 RENAL HAEMORRHAGE 17 0.0083
217 METASTASES TO PERITONEUM 21 0.0083
218 MOUTH ULCERATION 175 0.0083
219 OESOPHAGEAL VARICES HAEMORRHAGE 18 0.0083
220 BLOOD POTASSIUM ABNORMAL 22 0.0082
221 TOOTHACHE 147 0.0081
222 NEPHRECTOMY 12 0.0081
223 CHAPPED LIPS 35 0.0081
224 ANAL ABSCESS 43 0.0080
225 FAECES HARD 31 0.0080
226 OFF LABEL USE 6932 0.0079
227 INFECTIOUS PLEURAL EFFUSION 12 0.0079
228 DRUG INTOLERANCE 756 0.0078
229 OSTEONECROSIS OF JAW 190 0.0077
230 SKIN LESION 208 0.0076
231 ODYNOPHAGIA 45 0.0075
232 TONGUE COATED 13 0.0075
233 METASTASES TO MENINGES 17 0.0075
234 MOUTH SWELLING 43 0.0074
235 HEPATIC CYTOLYSIS 95 0.0074
236 GINGIVITIS 40 0.0074
237 BLOOD POTASSIUM DECREASED 222 0.0074
238 BLOOD PRESSURE SYSTOLIC INCREASED 143 0.0073
239 PROCTALGIA 47 0.0073
240 GINGIVAL DISORDER 28 0.0073
241 RENAL MASS 15 0.0073
242 POLYCYTHAEMIA 15 0.0073
243 LUNG NEOPLASM 31 0.0073
244 VOCAL CORD PARALYSIS 13 0.0072
245 MOUTH HAEMORRHAGE 53 0.0072
246 EMBOLISM 60 0.0072
247 OROPHARYNGEAL PAIN 665 0.0072
248 INTESTINAL PERFORATION 80 0.0071
249 ASPARTATE AMINOTRANSFERASE INCREASED 376 0.0071
250 DEHYDRATION 935 0.0070
251 ANORECTAL DISCOMFORT 37 0.0070
252 ANAL FISTULA 37 0.0069
253 TONGUE DISORDER 49 0.0068
254 GINGIVAL RECESSION 13 0.0068
255 PROTEIN TOTAL INCREASED 18 0.0068
256 ASCITES 196 0.0067
257 HYPERSOMNIA 188 0.0066
258 PNEUMOPERITONEUM 12 0.0065
259 HYPOPHAGIA 166 0.0065
260 ALANINE AMINOTRANSFERASE INCREASED 398 0.0065
261 HAEMORRHOIDS 126 0.0065
262 CANDIDA INFECTION 109 0.0064
263 CARDIAC DYSFUNCTION 24 0.0064
264 PRODUCT SUPPLY ISSUE 46 0.0064
265 BLOOD BLISTER 20 0.0064
266 MUSCULOSKELETAL CHEST PAIN 99 0.0064
267 PRURITUS GENITAL 15 0.0064
268 OSTEOLYSIS 13 0.0064
269 NAUSEA 5032 0.0064
270 FAILURE TO THRIVE 33 0.0063
271 INFECTED SKIN ULCER 12 0.0063
272 ULCER 101 0.0063
273 EATING DISORDER 135 0.0063
274 HEPATIC ENCEPHALOPATHY 59 0.0063
275 PULMONARY MASS 94 0.0063
276 LIMB DISCOMFORT 195 0.0063
277 VITAMIN B12 DECREASED 18 0.0062
278 BLOOD PRESSURE ABNORMAL 124 0.0062
279 ORAL FUNGAL INFECTION 17 0.0062
280 SKIN DISCOLOURATION 282 0.0061
281 PLEURAL EFFUSION 373 0.0061
282 HYPOCALCAEMIA 116 0.0061
283 PAIN IN EXTREMITY 1796 0.0061
284 HICCUPS 50 0.0061
285 RADIATION PNEUMONITIS 13 0.0061
286 OESOPHAGEAL PAIN 24 0.0061
287 LUNG OPACITY 16 0.0061
288 FURUNCLE 48 0.0061
289 BLOOD PHOSPHORUS DECREASED 22 0.0060
290 MALNUTRITION 67 0.0060
291 PNEUMONITIS 163 0.0060
292 BLOOD POTASSIUM INCREASED 97 0.0060
293 HEPATOTOXICITY 133 0.0060
294 MUCOSAL DRYNESS 12 0.0060
295 BLOOD URINE PRESENT 112 0.0059
296 HOSPICE CARE 58 0.0059
297 LACTOSE INTOLERANCE 15 0.0059
298 TUMOUR MARKER INCREASED 28 0.0058
299 CACHEXIA 30 0.0058
300 ASTHENIA 2177 0.0058
301 BLOOD CREATININE ABNORMAL 20 0.0058
302 OROPHARYNGEAL DISCOMFORT 52 0.0058
303 HAEMOGLOBIN INCREASED 26 0.0057
304 PAIN IN JAW 161 0.0057
305 EPISTAXIS 423 0.0056
306 ADRENOCORTICAL INSUFFICIENCY ACUTE 11 0.0056
307 ABDOMINAL DISCOMFORT 941 0.0056
308 FLUID INTAKE REDUCED 28 0.0056
309 RASH VESICULAR 27 0.0056
310 HAEMORRHOIDAL HAEMORRHAGE 27 0.0055
311 PIGMENTATION DISORDER 34 0.0055
312 HYPOAESTHESIA ORAL 83 0.0055
313 PULMONARY INFARCTION 13 0.0055
314 COLITIS 208 0.0055
315 SKIN PAPILLOMA 22 0.0055
316 PUSTULE 13 0.0055
317 INTERSTITIAL LUNG DISEASE 265 0.0055
318 FOOD INTOLERANCE 20 0.0055
319 HYPOMAGNESAEMIA 76 0.0055
320 PAROSMIA 41 0.0054
321 CHOLECYSTITIS INFECTIVE 15 0.0054
322 TERMINAL STATE 36 0.0054
323 ADVERSE EVENT 496 0.0054
324 ENTEROCOLITIS 31 0.0054
325 WOUND 150 0.0054
326 BLOOD LACTATE DEHYDROGENASE INCREASED 85 0.0054
327 HEPATIC LESION 23 0.0053
328 NASAL DISCOMFORT 42 0.0053
329 PULMONARY EMBOLISM 503 0.0053
330 LIP DRY 48 0.0053
331 PARANASAL SINUS HYPERSECRETION 20 0.0052
332 MASTICATION DISORDER 16 0.0052
333 ANAL FISSURE 28 0.0052
334 PERIPHERAL SWELLING 804 0.0052
335 HEPATIC NEOPLASM 17 0.0052
336 BLOOD TEST ABNORMAL 73 0.0052
337 PLATELET COUNT DECREASED 551 0.0052
338 SKIN WRINKLING 14 0.0051
339 GASTRIC PERFORATION 14 0.0051
340 GOUT 92 0.0051
341 FLANK PAIN 48 0.0051
342 CHOLECYSTITIS ACUTE 29 0.0051
343 ORAL INFECTION 20 0.0051
344 RENAL PAIN 54 0.0051
345 RASH MACULAR 178 0.0051
346 DYSPEPSIA 500 0.0051
347 SKIN ABRASION 24 0.0051
348 LIVER FUNCTION TEST ABNORMAL 147 0.0050
349 METASTASIS 36 0.0050
350 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 48 0.0050
351 WEIGHT ABNORMAL 12 0.0050
352 PAINFUL RESPIRATION 12 0.0050
353 WEIGHT FLUCTUATION 52 0.0050
354 BLOOD CREATINE INCREASED 22 0.0050
355 LOOSE TOOTH 16 0.0050
356 GASTROOESOPHAGEAL REFLUX DISEASE 399 0.0050
357 FUNGAL SKIN INFECTION 20 0.0049
358 SKIN FRAGILITY 12 0.0049
359 ABSCESS LIMB 21 0.0049
360 DISEASE PROGRESSION 581 0.0049
361 DYSPHAGIA 463 0.0049
362 HYPOPHOSPHATAEMIA 36 0.0049
363 CHOLECYSTITIS 58 0.0049
364 BLOOD THYROID STIMULATING HORMONE DECREASED 22 0.0048
365 BLOOD IRON DECREASED 57 0.0048
366 VOMITING 2249 0.0048
367 RED BLOOD CELL COUNT INCREASED 13 0.0047
368 GALLBLADDER DISORDER 84 0.0047
369 ADVERSE REACTION 62 0.0047
370 BLOOD CALCIUM INCREASED 41 0.0047
371 PORTAL VEIN THROMBOSIS 15 0.0046
372 BLOOD PRESSURE DECREASED 308 0.0046
373 TRANSAMINASES INCREASED 103 0.0046
374 NECK MASS 13 0.0046
375 AORTIC DISSECTION 19 0.0046
376 THROMBOSIS 367 0.0046
377 PARONYCHIA 20 0.0045
378 GUILLAIN-BARRE SYNDROME 22 0.0045
379 HEPATITIS 116 0.0045
380 GASTROINTESTINAL STROMAL TUMOUR 12 0.0045
381 CHOLANGITIS 28 0.0045
382 BLOOD BILIRUBIN INCREASED 122 0.0045
383 NEUROPATHY PERIPHERAL 428 0.0045
384 THERAPY PARTIAL RESPONDER 70 0.0045
385 YELLOW SKIN 21 0.0045
386 SCAB 51 0.0045
387 TEMPERATURE INTOLERANCE 46 0.0045
388 HEPATIC PAIN 19 0.0044
389 ABDOMINAL PAIN UPPER 913 0.0044
390 PAIN OF SKIN 119 0.0044
391 ORAL CANDIDIASIS 58 0.0044
392 SKIN REACTION 62 0.0044
393 PULMONARY TOXICITY 31 0.0044
394 ACNE 332 0.0044
395 SPINAL CORD COMPRESSION 17 0.0044
396 ILLNESS 449 0.0044
397 PROSTATOMEGALY 17 0.0043
398 LIVER ABSCESS 14 0.0043
399 BOWEL MOVEMENT IRREGULARITY 33 0.0043
400 ABDOMINAL INFECTION 11 0.0043
401 RASH 1874 0.0043
402 HYPERCALCAEMIA 53 0.0043
403 MYOCARDITIS 49 0.0043
404 HAEMOPTYSIS 119 0.0043
405 DYSCHEZIA 13 0.0043
406 EJECTION FRACTION DECREASED 66 0.0042
407 ELECTROLYTE IMBALANCE 49 0.0042
408 NEPHRITIS 14 0.0042
409 MALAISE 1826 0.0042
410 ALOPECIA 815 0.0041
411 BRAIN NEOPLASM 38 0.0041
412 MYOSITIS 37 0.0041
413 TONGUE DISCOLOURATION 18 0.0041
414 DUODENAL ULCER 29 0.0041
415 RASH PRURITIC 219 0.0040
416 RENAL DISORDER 188 0.0040
417 LABORATORY TEST ABNORMAL 118 0.0040
418 POSTOPERATIVE WOUND INFECTION 27 0.0040
419 RETCHING 83 0.0039
420 PYODERMA GANGRENOSUM 14 0.0039
421 SUNBURN 29 0.0039
422 TOOTH INFECTION 51 0.0039
423 ERYTHEMA MULTIFORME 36 0.0039
424 CUTANEOUS VASCULITIS 14 0.0038
425 PNEUMONIA BACTERIAL 35 0.0038
426 BURNING SENSATION 267 0.0038
427 HYPONATRAEMIA 214 0.0038
428 MUSCLE SPASMS 697 0.0038
429 PERICARDIAL EFFUSION 87 0.0038
430 MUSCLE STRAIN 32 0.0037
431 ERYTHEMA 757 0.0037
432 QUALITY OF LIFE DECREASED 49 0.0036
433 CEREBRAL DISORDER 27 0.0036
434 MASS 51 0.0036
435 BLOOD CREATINE PHOSPHOKINASE INCREASED 105 0.0036
436 GASTROINTESTINAL SOUNDS ABNORMAL 18 0.0036
437 HAEMOGLOBIN ABNORMAL 23 0.0036
438 HAEMATURIA 122 0.0036
439 TOOTH ABSCESS 36 0.0035
440 GROIN PAIN 31 0.0035
441 POOR PERIPHERAL CIRCULATION 15 0.0035
442 PANCREATITIS 184 0.0035
443 PLATELET COUNT ABNORMAL 21 0.0035
444 PARAESTHESIA ORAL 50 0.0035
445 GENERAL PHYSICAL HEALTH DETERIORATION 401 0.0035
446 DERMATITIS BULLOUS 25 0.0035
447 PANCREATIC DISORDER 17 0.0034
448 BLOOD CREATININE INCREASED 225 0.0034
449 PRODUCT DOSE OMISSION ISSUE 1013 0.0034
450 DEATH 2957 0.0034
451 GASTRIC ULCER HAEMORRHAGE 19 0.0034
452 THERMAL BURN 24 0.0034
453 SPINAL DISORDER 32 0.0034
454 OESOPHAGEAL DISORDER 13 0.0034
455 ANAL INCONTINENCE 30 0.0033
456 DRUG ERUPTION 59 0.0033
457 LYMPHOEDEMA 23 0.0033
458 ENCEPHALITIS 23 0.0033
459 PULMONARY HAEMORRHAGE 26 0.0033
460 SKIN IRRITATION 152 0.0033
461 PEMPHIGOID 25 0.0033
462 RENAL IMPAIRMENT 278 0.0033
463 OESOPHAGITIS 36 0.0033
464 TRISMUS 17 0.0033
465 GAIT INABILITY 110 0.0033
466 NEURALGIA 80 0.0033
467 JAW DISORDER 18 0.0033
468 DENTAL CARIES 36 0.0033
469 OEDEMA 176 0.0032
470 DECREASED ACTIVITY 35 0.0032
471 SLUGGISHNESS 33 0.0032
472 NEOPLASM PROGRESSION 112 0.0032
473 RED BLOOD CELL COUNT DECREASED 92 0.0032
474 FISTULA 36 0.0032
475 PRURITUS 1230 0.0032
476 ONYCHOCLASIS 22 0.0032
477 ABSCESS 51 0.0032
478 PERIPHERAL ISCHAEMIA 13 0.0032
479 AUTOIMMUNE HEPATITIS 22 0.0032
480 VITAMIN D DECREASED 27 0.0032
481 TYPE 1 DIABETES MELLITUS 19 0.0032
482 FAECES DISCOLOURED 68 0.0031
483 WHITE BLOOD CELL COUNT ABNORMAL 20 0.0031
484 BRAIN FOG 49 0.0031
485 OESOPHAGEAL ULCER 12 0.0031
486 EAR DISCOMFORT 32 0.0031
487 CLOSTRIDIUM DIFFICILE COLITIS 33 0.0031
488 PRODUCT PRESCRIBING ERROR 74 0.0031
489 GASTRIC ULCER 59 0.0031
490 ULCER HAEMORRHAGE 21 0.0031
491 BLOOD GLUCOSE DECREASED 149 0.0031
492 BONE PAIN 181 0.0031
493 EAR PAIN 60 0.0031
494 BACK DISORDER 50 0.0031
495 POST PROCEDURAL INFECTION 25 0.0031
496 CHOLESTASIS 59 0.0031
497 SHOCK HAEMORRHAGIC 25 0.0031
498 TUMOUR LYSIS SYNDROME 27 0.0031
499 PHARYNGEAL SWELLING 30 0.0031
500 BLOOD ALKALINE PHOSPHATASE INCREASED 76 0.0031
501 PRODUCTIVE COUGH 146 0.0031
502 DERMATITIS 64 0.0031
503 ABNORMAL FAECES 25 0.0030
504 RHINORRHOEA 197 0.0030
505 ANOSMIA 44 0.0030
506 CORONAVIRUS INFECTION 20 0.0030
507 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 145 0.0030
508 LOCALISED INFECTION 73 0.0030
509 BACK PAIN 697 0.0030
510 CONTUSION 288 0.0030
511 MYASTHENIA GRAVIS 24 0.0030
512 THROAT IRRITATION 133 0.0030
513 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 15 0.0030
514 ABDOMINAL PAIN 688 0.0030
515 RECURRENT CANCER 12 0.0029
516 SKIN INFECTION 33 0.0029
517 ABDOMINAL ABSCESS 13 0.0029
518 INCREASED TENDENCY TO BRUISE 27 0.0029
519 HUMERUS FRACTURE 14 0.0029
520 DYSPNOEA EXERTIONAL 109 0.0029
521 SINUS DISORDER 57 0.0029
522 URINARY TRACT INFECTION 489 0.0029
523 BRAIN OEDEMA 36 0.0028
524 ABDOMINAL DISTENSION 296 0.0028
525 PROSTATIC SPECIFIC ANTIGEN INCREASED 39 0.0028
526 ORAL HERPES 55 0.0028
527 PURULENT DISCHARGE 12 0.0028
528 INTERNAL HAEMORRHAGE 32 0.0028
529 HYPERAESTHESIA 23 0.0028
530 HERNIA 54 0.0028
531 ERUCTATION 54 0.0028
532 LETHARGY 159 0.0028
533 ILEUS 34 0.0027
534 FEELING COLD 76 0.0027
535 DIZZINESS POSTURAL 26 0.0027
536 APPENDICITIS 25 0.0027
537 GASTRITIS 70 0.0027
538 GENERAL PHYSICAL CONDITION ABNORMAL 18 0.0027
539 HEPATIC FAILURE 80 0.0027
540 GASTROINTESTINAL DISORDER 237 0.0026
541 NOCTURIA 32 0.0026
542 SECRETION DISCHARGE 33 0.0026
543 SKIN HAEMORRHAGE 39 0.0026
544 TOOTH FRACTURE 29 0.0026
545 INGUINAL HERNIA 16 0.0026
546 FULL BLOOD COUNT DECREASED 53 0.0026
547 CHROMATURIA 59 0.0026
548 COMPRESSION FRACTURE 14 0.0026
549 CONFUSIONAL STATE 422 0.0026
550 NODULE 34 0.0026
551 SALIVARY HYPERSECRETION 26 0.0026
552 HYPOKALAEMIA 119 0.0026
553 BLOOD UREA INCREASED 43 0.0026
554 OEDEMA PERIPHERAL 312 0.0026
555 ANAEMIA 488 0.0026
556 FAECALOMA 14 0.0026
557 UPPER-AIRWAY COUGH SYNDROME 21 0.0025
558 CARDIAC FAILURE 204 0.0025
559 PROSTATIC DISORDER 14 0.0025
560 SWOLLEN TONGUE 79 0.0025
561 MUSCLE ATROPHY 32 0.0025
562 MEMORY IMPAIRMENT 346 0.0025
563 BENIGN PROSTATIC HYPERPLASIA 13 0.0025
564 NECROSIS 14 0.0025
565 NIGHT SWEATS 81 0.0025
566 MELAENA 55 0.0025
567 PURPURA 22 0.0025
568 SEASONAL ALLERGY 35 0.0025
569 FACIAL PAIN 22 0.0025
570 TRANSIENT ISCHAEMIC ATTACK 83 0.0025
571 HAEMATEMESIS 62 0.0024
572 FREQUENT BOWEL MOVEMENTS 66 0.0024
573 PNEUMONIA ASPIRATION 61 0.0024
574 RENAL CANCER 116 0.0024
575 CLOSTRIDIUM DIFFICILE INFECTION 53 0.0024
576 PHOTOSENSITIVITY REACTION 40 0.0024
577 DEEP VEIN THROMBOSIS 157 0.0024
578 PERIPHERAL COLDNESS 33 0.0024
579 EOSINOPHIL COUNT INCREASED 20 0.0024
580 MYALGIA 408 0.0024
581 HYPERKALAEMIA 84 0.0024
582 SPINAL PAIN 28 0.0024
583 THROMBOCYTOPENIA 266 0.0024
584 WOUND INFECTION 26 0.0024
585 THROMBOTIC MICROANGIOPATHY 23 0.0024
586 BONE DISORDER 43 0.0024
587 PLEURISY 14 0.0024
588 DIVERTICULITIS 65 0.0023
589 ACUTE RESPIRATORY FAILURE 45 0.0023
590 THERAPY CHANGE 23 0.0023
591 RASH MACULO-PAPULAR 52 0.0023
592 HYPERTENSIVE CRISIS 26 0.0023
593 TOOTH EXTRACTION 29 0.0023
594 HEPATITIS CHOLESTATIC 14 0.0023
595 SEPSIS 259 0.0023
596 LIMB INJURY 63 0.0023
597 FOLLICULITIS 24 0.0023
598 LYMPHADENOPATHY 81 0.0023
599 NAIL DISORDER 20 0.0023
600 ARTHRALGIA 944 0.0023
601 FULL BLOOD COUNT ABNORMAL 24 0.0023
602 SUDDEN DEATH 24 0.0023
603 MUSCULOSKELETAL DISCOMFORT 39 0.0023
604 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 17 0.0023
605 GENERALISED OEDEMA 28 0.0023
606 CARDIAC FAILURE ACUTE 15 0.0022
607 GASTROINTESTINAL INFECTION 20 0.0022
608 HYPOAESTHESIA 331 0.0022
609 HYPERCHLORHYDRIA 13 0.0022
610 SKIN LACERATION 24 0.0022
611 PALLOR 60 0.0022
612 ENCEPHALOPATHY 54 0.0022
613 GLOMERULAR FILTRATION RATE DECREASED 27 0.0022
614 SINUS HEADACHE 13 0.0022
615 ENTERITIS 14 0.0022
616 COUGH 611 0.0022
617 CYST 27 0.0022
618 BALANCE DISORDER 188 0.0022
619 ATELECTASIS 21 0.0022
620 FUNGAL INFECTION 72 0.0022
621 NEUTROPHIL COUNT DECREASED 88 0.0022
622 OSTEOMYELITIS 39 0.0022
623 WHITE BLOOD CELL COUNT DECREASED 233 0.0021
624 HAEMATOCHEZIA 118 0.0021
625 HYPERBILIRUBINAEMIA 22 0.0021
626 PARAESTHESIA 334 0.0021
627 DIZZINESS 1058 0.0021
628 FRACTURE 40 0.0021
629 MUSCULAR WEAKNESS 240 0.0021
630 NECK PAIN 118 0.0021
631 SOMNOLENCE 425 0.0021
632 PHARYNGITIS 26 0.0021
633 ABDOMINAL PAIN LOWER 53 0.0021
634 GAIT DISTURBANCE 399 0.0021
635 INTESTINAL OBSTRUCTION 78 0.0021
636 FLUID RETENTION 105 0.0021
637 UROSEPSIS 19 0.0021
638 URINE OUTPUT DECREASED 18 0.0021
639 ABNORMAL LOSS OF WEIGHT 14 0.0021
640 CEREBRAL INFARCTION 50 0.0020
641 ELECTROCARDIOGRAM ABNORMAL 16 0.0020
642 PAIN 1245 0.0020
643 JAUNDICE 54 0.0020
644 PANCREATITIS ACUTE 45 0.0020
645 PAPULE 14 0.0020
646 RASH ERYTHEMATOUS 95 0.0020
647 MENTAL STATUS CHANGES 55 0.0020
648 RECTAL HAEMORRHAGE 85 0.0020
649 CEREBRAL HAEMORRHAGE 70 0.0020
650 NERVE COMPRESSION 18 0.0019
651 SMALL INTESTINAL OBSTRUCTION 24 0.0019
652 ESCHERICHIA INFECTION 16 0.0019
653 INCREASED APPETITE 37 0.0019
654 DIARRHOEA HAEMORRHAGIC 18 0.0019
655 RASH PUSTULAR 14 0.0019
656 HAEMORRHAGIC STROKE 15 0.0019
657 GAMMA-GLUTAMYLTRANSFERASE INCREASED 42 0.0019
658 SCIATICA 30 0.0019
659 HAEMORRHAGE 195 0.0019
660 CHEST PAIN 344 0.0019
661 PYREXIA 642 0.0019
662 DEFAECATION URGENCY 13 0.0019
663 GASTROENTERITIS 27 0.0018
664 ARTHROPATHY 102 0.0018
665 ACUTE MYOCARDIAL INFARCTION 54 0.0018
666 GASTROINTESTINAL PAIN 20 0.0018
667 LYMPHOCYTE COUNT DECREASED 32 0.0018
668 TOXICITY TO VARIOUS AGENTS 305 0.0018
669 PROCEDURAL PAIN 50 0.0018
670 CHOLELITHIASIS 59 0.0018
671 CARDIOTOXICITY 16 0.0018
672 DYSURIA 66 0.0018
673 PNEUMOCYSTIS JIROVECII PNEUMONIA 18 0.0018
674 LIVER INJURY 44 0.0018
675 JOINT STIFFNESS 47 0.0018
676 PNEUMONIA 580 0.0018
677 GASTROINTESTINAL INFLAMMATION 14 0.0018
678 TOXIC SKIN ERUPTION 18 0.0018
679 HAEMOGLOBIN DECREASED 183 0.0018
680 COLITIS ISCHAEMIC 12 0.0018
681 GASTROENTERITIS VIRAL 32 0.0018
682 HYPOACUSIS 76 0.0018
683 COVID-19 309 0.0018
684 UPPER LIMB FRACTURE 35 0.0018
685 HEADACHE 1100 0.0018
686 INSOMNIA 467 0.0018
687 RIB FRACTURE 36 0.0017
688 BEDRIDDEN 23 0.0017
689 DISORIENTATION 69 0.0017
690 FRUSTRATION TOLERANCE DECREASED 14 0.0017
691 C-REACTIVE PROTEIN INCREASED 63 0.0017
692 CELLULITIS 87 0.0017
693 INFECTION 249 0.0017
694 PULMONARY OEDEMA 77 0.0017
695 POOR QUALITY SLEEP 37 0.0017
696 BACTERIAL INFECTION 32 0.0017
697 TROPONIN INCREASED 13 0.0017
698 SLEEP DISORDER 120 0.0017
699 DIPLOPIA 44 0.0017
700 INFLAMMATION 87 0.0017
701 DEPRESSED MOOD 89 0.0017
702 LUNG DISORDER 82 0.0017
703 DERMATITIS ALLERGIC 21 0.0017
704 DYSPNOEA 940 0.0017
705 DRUG-INDUCED LIVER INJURY 52 0.0017
706 HUNGER 23 0.0016
707 ACUTE KIDNEY INJURY 250 0.0016
708 POST PROCEDURAL HAEMORRHAGE 19 0.0016
709 DEVICE RELATED INFECTION 25 0.0016
710 THIRST 29 0.0016
711 HERPES ZOSTER 93 0.0016
712 NASOPHARYNGITIS 296 0.0016
713 HYDRONEPHROSIS 12 0.0016
714 EYE INFECTION 18 0.0016
715 HEMIPARESIS 27 0.0016
716 SARS-COV-2 TEST POSITIVE 21 0.0016
717 ACCIDENTAL OVERDOSE 58 0.0016
718 UNEVALUABLE EVENT 119 0.0016
719 CARDIOMYOPATHY 23 0.0016
720 ASPIRATION 17 0.0016
721 HEPATOCELLULAR INJURY 22 0.0016
722 SENSATION OF FOREIGN BODY 13 0.0015
723 VITAMIN D DEFICIENCY 15 0.0015
724 SINUSITIS 157 0.0015
725 SPEECH DISORDER 80 0.0015
726 BODY TEMPERATURE DECREASED 15 0.0015
727 HIP FRACTURE 49 0.0015
728 BLOOD COUNT ABNORMAL 23 0.0015
729 SEPTIC SHOCK 66 0.0015
730 NASAL CONGESTION 89 0.0015
731 HYPERGLYCAEMIA 55 0.0015
732 CHILLS 176 0.0015
733 URINARY RETENTION 50 0.0015
734 BLOOD DISORDER 12 0.0015
735 DISSEMINATED INTRAVASCULAR COAGULATION 21 0.0015
736 RENAL FAILURE 198 0.0015
737 ATRIAL FIBRILLATION 144 0.0015
738 CYSTITIS 47 0.0015
739 HEAD DISCOMFORT 26 0.0015
740 HIATUS HERNIA 19 0.0015
741 SUPRAVENTRICULAR TACHYCARDIA 14 0.0015
742 AMNESIA 95 0.0015
743 BLOOD GLUCOSE FLUCTUATION 16 0.0015
744 ISCHAEMIC STROKE 26 0.0015
745 CENTRAL NERVOUS SYSTEM LESION 20 0.0015
746 SPINAL COMPRESSION FRACTURE 12 0.0014
747 MUSCULOSKELETAL PAIN 76 0.0014
748 HEMIPLEGIA 12 0.0014
749 STEVENS-JOHNSON SYNDROME 32 0.0014
750 POLLAKIURIA 60 0.0014
751 HEPATOMEGALY 14 0.0014
752 SCRATCH 15 0.0014
753 PANCYTOPENIA 79 0.0014
754 VIRAL INFECTION 47 0.0014
755 SINUS CONGESTION 19 0.0014
756 VISUAL IMPAIRMENT 174 0.0014
757 DRUG RESISTANCE 36 0.0014
758 GASTROINTESTINAL HAEMORRHAGE 117 0.0014
759 GASTRIC DISORDER 48 0.0014
760 THINKING ABNORMAL 26 0.0014
761 PRODUCT DOSE OMISSION 91 0.0014
762 SEIZURE 161 0.0014
763 VENTRICULAR TACHYCARDIA 23 0.0014
764 IMPAIRED QUALITY OF LIFE 20 0.0014
765 CEREBROVASCULAR ACCIDENT 235 0.0014
766 HEPATIC CIRRHOSIS 26 0.0014
767 DRY EYE 69 0.0014
768 CARDIAC DISORDER 129 0.0014
769 SWELLING 129 0.0014
770 ORTHOSTATIC HYPOTENSION 24 0.0014
771 HEART RATE INCREASED 136 0.0014
772 RESPIRATORY FAILURE 100 0.0014
773 FALL 456 0.0014
774 PRESCRIBED UNDERDOSE 27 0.0014
775 PERITONITIS 28 0.0014
776 PETECHIAE 14 0.0013
777 EYE DISORDER 44 0.0013
778 VISION BLURRED 183 0.0013
779 FEELING ABNORMAL 319 0.0013
780 INCONTINENCE 14 0.0013
781 ACUTE HEPATIC FAILURE 18 0.0013
782 EXOSTOSIS 12 0.0013
783 HAEMATOCRIT DECREASED 26 0.0013
784 HEART RATE DECREASED 46 0.0013
785 JOINT SWELLING 158 0.0013
786 NEPHROLITHIASIS 60 0.0013
787 UPPER GASTROINTESTINAL HAEMORRHAGE 22 0.0013
788 GASTRIC HAEMORRHAGE 15 0.0013
789 BLOOD GLUCOSE ABNORMAL 24 0.0013
790 BACK INJURY 14 0.0013
791 HYPOXIA 45 0.0013
792 ARTHRITIS 100 0.0013
793 HAEMORRHAGE INTRACRANIAL 19 0.0013
794 HYPOGLYCAEMIA 61 0.0013
795 EOSINOPHILIA 22 0.0013
796 INFLUENZA 140 0.0013
797 TOOTH LOSS 26 0.0013
798 RASH PAPULAR 28 0.0012
799 DYSARTHRIA 47 0.0012
800 COGNITIVE DISORDER 58 0.0012
801 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 68 0.0012
802 INTENTIONAL DOSE OMISSION 35 0.0012
803 INTERNATIONAL NORMALISED RATIO INCREASED 35 0.0012
804 CYTOPENIA 15 0.0012
805 HYPOTENSION 245 0.0012
806 IMMUNE SYSTEM DISORDER 16 0.0012
807 CATARACT 72 0.0012
808 HEPATIC CANCER 29 0.0012
809 MADAROSIS 14 0.0012
810 SPINAL FRACTURE 24 0.0012
811 PULMONARY THROMBOSIS 13 0.0012
812 FEELING HOT 73 0.0012
813 BACTERAEMIA 14 0.0012
814 KIDNEY INFECTION 23 0.0012
815 LIP SWELLING 39 0.0012
816 HYPOKINESIA 17 0.0012
817 HEAD INJURY 37 0.0012
818 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 12 0.0012
819 HAEMATOMA 30 0.0012
820 SWELLING FACE 75 0.0012
821 POST PROCEDURAL COMPLICATION 22 0.0011
822 MYELOSUPPRESSION 41 0.0011
823 COLD SWEAT 20 0.0011
824 HYPERHIDROSIS 145 0.0011
825 ALTERED STATE OF CONSCIOUSNESS 24 0.0011
826 PRODUCT DISPENSING ERROR 24 0.0011
827 PELVIC PAIN 20 0.0011
828 HOSPITALISATION 169 0.0011
829 DELIRIUM 38 0.0011
830 MULTIPLE ORGAN DYSFUNCTION SYNDROME 31 0.0011
831 LACRIMATION INCREASED 33 0.0011
832 VERTIGO 66 0.0011
833 FOOT DEFORMITY 12 0.0011
834 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 219 0.0011
835 NEPHROPATHY TOXIC 12 0.0011
836 HEART RATE IRREGULAR 24 0.0011
837 DYSSTASIA 31 0.0011
838 APHASIA 32 0.0011
839 MYOCARDIAL ISCHAEMIA 12 0.0011
840 MUSCULOSKELETAL DISORDER 20 0.0010
841 UPPER RESPIRATORY TRACT INFECTION 48 0.0010
842 LOSS OF CONSCIOUSNESS 133 0.0010
843 ECZEMA 54 0.0010
844 EAR INFECTION 27 0.0010
845 URINARY INCONTINENCE 30 0.0010
846 ANGINA PECTORIS 29 0.0010
847 LOWER RESPIRATORY TRACT INFECTION 46 0.0010
848 PRODUCT AVAILABILITY ISSUE 23 0.0010
849 PLATELET COUNT INCREASED 13 0.0010
850 HOT FLUSH 75 0.0010
851 PRODUCT ADMINISTRATION ERROR 20 0.0010
852 SURGERY 58 0.0010
853 BURSITIS 12 0.0010
854 ILL-DEFINED DISORDER 60 0.0010
855 BODY TEMPERATURE INCREASED 20 0.0010
856 TINNITUS 45 0.0010
857 NO ADVERSE EVENT 177 0.0010
858 HEPATIC STEATOSIS 18 0.0010
859 UVEITIS 13 0.0010
860 MYOCARDIAL INFARCTION 166 0.0010
861 DISCOMFORT 58 0.0009
862 ANXIETY 270 0.0009
863 DEPRESSION 214 0.0009
864 SNEEZING 21 0.0009
865 MUSCLE TIGHTNESS 15 0.0009
866 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
867 DIALYSIS 13 0.0009
868 EPILEPSY 28 0.0009
869 OSTEONECROSIS 30 0.0009
870 DISTURBANCE IN ATTENTION 49 0.0009
871 ROAD TRAFFIC ACCIDENT 38 0.0009
872 CHEST DISCOMFORT 93 0.0009
873 PARALYSIS 13 0.0009
874 CARDIOGENIC SHOCK 13 0.0009
875 ACUTE RESPIRATORY DISTRESS SYNDROME 16 0.0009
876 NEOPLASM MALIGNANT 60 0.0009
877 DRUG INTERACTION 141 0.0009
878 PRODUCT USE COMPLAINT 14 0.0009
879 NEUTROPENIA 120 0.0009
880 RESPIRATORY TRACT CONGESTION 14 0.0009
881 BLOOD CHOLESTEROL INCREASED 41 0.0009
882 SCAR 15 0.0009
883 THERAPY INTERRUPTED 62 0.0009
884 PRESYNCOPE 21 0.0009
885 ELECTROCARDIOGRAM QT PROLONGED 31 0.0009
886 TREMOR 143 0.0009
887 SYNCOPE 86 0.0009
888 CORONARY ARTERY DISEASE 26 0.0009
889 WEIGHT INCREASED 192 0.0009
890 MUSCULOSKELETAL STIFFNESS 75 0.0009
891 TUBULOINTERSTITIAL NEPHRITIS 16 0.0009
892 BRONCHITIS 63 0.0009
893 MOOD SWINGS 27 0.0008
894 THERAPY NON-RESPONDER 38 0.0008
895 RESPIRATORY TRACT INFECTION 22 0.0008
896 BLOOD GLUCOSE INCREASED 159 0.0008
897 DEAFNESS 22 0.0008
898 TREATMENT NONCOMPLIANCE 46 0.0008
899 DIABETES MELLITUS 64 0.0008
900 RHABDOMYOLYSIS 35 0.0008
901 OXYGEN SATURATION DECREASED 47 0.0008
902 CHRONIC KIDNEY DISEASE 63 0.0008
903 RESTLESS LEGS SYNDROME 15 0.0008
904 DEMENTIA 23 0.0008
905 HALLUCINATION 62 0.0008
906 FEBRILE NEUTROPENIA 53 0.0008
907 TACHYCARDIA 69 0.0008
908 FEMUR FRACTURE 24 0.0008
909 MENTAL DISORDER 33 0.0008
910 CONJUNCTIVITIS 14 0.0008
911 SKIN BURNING SENSATION 54 0.0008
912 AGRANULOCYTOSIS 14 0.0008
913 CYTOKINE RELEASE SYNDROME 15 0.0007
914 SKIN CANCER 16 0.0007
915 THERAPY CESSATION 38 0.0007
916 ARRHYTHMIA 35 0.0007
917 LOWER LIMB FRACTURE 14 0.0007
918 PRESCRIBED OVERDOSE 14 0.0007
919 INFLUENZA LIKE ILLNESS 59 0.0007
920 DIABETIC KETOACIDOSIS 17 0.0007
921 CIRCULATORY COLLAPSE 12 0.0007
922 WHITE BLOOD CELL COUNT INCREASED 27 0.0007
923 UNRESPONSIVE TO STIMULI 18 0.0007
924 DRUG INEFFECTIVE 910 0.0007
925 METABOLIC ACIDOSIS 22 0.0007
926 EYE PRURITUS 23 0.0007
927 AMENORRHOEA 12 0.0007
928 SLEEP APNOEA SYNDROME 13 0.0007
929 CARDIAC FAILURE CONGESTIVE 54 0.0007
930 NERVOUSNESS 35 0.0007
931 STAPHYLOCOCCAL INFECTION 22 0.0007
932 THROAT TIGHTNESS 18 0.0007
933 MENTAL IMPAIRMENT 16 0.0007
934 LEUKOPENIA 33 0.0007
935 RASH GENERALISED 17 0.0007
936 MIDDLE INSOMNIA 12 0.0006
937 CARDIAC ARREST 51 0.0006
938 RESPIRATORY DISTRESS 17 0.0006
939 NERVOUS SYSTEM DISORDER 19 0.0006
940 RESPIRATORY DISORDER 18 0.0006
941 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
942 EYE SWELLING 22 0.0006
943 CONDITION AGGRAVATED 179 0.0006
944 MIGRAINE 56 0.0006
945 COLITIS ULCERATIVE 25 0.0006
946 THERAPEUTIC RESPONSE UNEXPECTED 25 0.0006
947 INTENTIONAL PRODUCT USE ISSUE 47 0.0005
948 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 38 0.0005
949 HYPERSENSITIVITY 99 0.0005
950 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
951 GLYCOSYLATED HAEMOGLOBIN INCREASED 13 0.0005
952 EYE PAIN 29 0.0005
953 PALPITATIONS 60 0.0005
954 URTICARIA 82 0.0005
955 ABASIA 12 0.0005
956 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 25 0.0005
957 CARDIO-RESPIRATORY ARREST 20 0.0005
958 MOBILITY DECREASED 34 0.0005
959 CARDIOVASCULAR DISORDER 12 0.0005
960 OVERDOSE 101 0.0005
961 RESTLESSNESS 17 0.0005
962 LUNG NEOPLASM MALIGNANT 19 0.0005
963 PSORIASIS 60 0.0005
964 INFUSION RELATED REACTION 30 0.0005
965 FLUSHING 46 0.0005
966 FEAR 12 0.0004
967 OCULAR HYPERAEMIA 21 0.0004
968 DYSKINESIA 17 0.0004
969 IRRITABILITY 25 0.0004
970 PANIC ATTACK 15 0.0004
971 RENAL INJURY 12 0.0004
972 DRUG ADMINISTRATION ERROR 12 0.0004
973 NIGHTMARE 13 0.0004
974 MOVEMENT DISORDER 12 0.0004
975 WHEEZING 22 0.0004
976 BLINDNESS 15 0.0004
977 AGITATION 26 0.0004
978 PRODUCT USE IN UNAPPROVED INDICATION 86 0.0003
979 OSTEOARTHRITIS 14 0.0003
980 THERAPEUTIC RESPONSE DECREASED 18 0.0003
981 ANGIOEDEMA 13 0.0003
982 BRADYCARDIA 15 0.0003
983 ABNORMAL BEHAVIOUR 11 0.0003
984 EYE IRRITATION 14 0.0002
985 DRUG DOSE OMISSION 40 0.0002
986 RHEUMATOID ARTHRITIS 27 0.0002
987 INJURY 16 0.0002
988 PRODUCT USE ISSUE 42 0.0002
989 PRODUCT STORAGE ERROR 19 0.0002
990 INTENTIONAL PRODUCT MISUSE 18 0.0002
991 PROSTATE CANCER 14 0.0002
992 INCORRECT DOSE ADMINISTERED 37 0.0002
993 EMOTIONAL DISTRESS 16 0.0001
994 INJECTION SITE PAIN 17 0.0001